209 related articles for article (PubMed ID: 21569348)
1. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.
Wang E; Bussom S; Chen J; Quinn C; Bedognetti D; Lam W; Guan F; Jiang Z; Mark Y; Zhao Y; Stroncek DF; White J; Marincola FM; Cheng YC
BMC Med Genomics; 2011 May; 4():38. PubMed ID: 21569348
[TBL] [Abstract][Full Text] [Related]
2. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
[TBL] [Abstract][Full Text] [Related]
3. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Lam W; Bussom S; Guan F; Jiang Z; Zhang W; Gullen EA; Liu SH; Cheng YC
Sci Transl Med; 2010 Aug; 2(45):45ra59. PubMed ID: 20720216
[TBL] [Abstract][Full Text] [Related]
4. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.
Xing S; Wang Y; Hu K; Wang F; Sun T; Li Q
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32812032
[TBL] [Abstract][Full Text] [Related]
5. PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.
Lam W; Jiang Z; Guan F; Huang X; Hu R; Wang J; Bussom S; Liu SH; Zhao H; Yen Y; Cheng YC
Sci Rep; 2015 Mar; 5():9384. PubMed ID: 25819872
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Kummar S; Copur MS; Rose M; Wadler S; Stephenson J; O'Rourke M; Brenckman W; Tilton R; Liu SH; Jiang Z; Su T; Cheng YC; Chu E
Clin Colorectal Cancer; 2011 Jun; 10(2):85-96. PubMed ID: 21859559
[TBL] [Abstract][Full Text] [Related]
7. Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
Zhang W; Saif MW; Dutschman GE; Li X; Lam W; Bussom S; Jiang Z; Ye M; Chu E; Cheng YC
J Chromatogr A; 2010 Sep; 1217(37):5785-93. PubMed ID: 20696432
[TBL] [Abstract][Full Text] [Related]
8. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
[TBL] [Abstract][Full Text] [Related]
9. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.
Liu SH; Cheng YC
J Ethnopharmacol; 2012 Apr; 140(3):614-23. PubMed ID: 22326673
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.
Rockwell S; Grove TA; Liu Y; Cheng YC; Higgins SA; Booth CJ
Int J Radiat Biol; 2013 Jan; 89(1):16-25. PubMed ID: 22856538
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
[TBL] [Abstract][Full Text] [Related]
12. A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.
Zhang Q; Zhang F; Li S; Liu R; Jin T; Dou Y; Zhou Z; Zhang J
Theranostics; 2019; 9(13):3732-3753. PubMed ID: 31281510
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.
Wu Y; Wang D; Yang X; Fu C; Zou L; Zhang J
Biomed Pharmacother; 2019 Jan; 109():2252-2261. PubMed ID: 30551482
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.
Naka T; Sugamura K; Hylander BL; Widmer MB; Rustum YM; Repasky EA
Cancer Res; 2002 Oct; 62(20):5800-6. PubMed ID: 12384541
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
Allegrini G; Goulette FA; Darnowski JW; Calabresi P
Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
[TBL] [Abstract][Full Text] [Related]
16. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
[TBL] [Abstract][Full Text] [Related]
17. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
[TBL] [Abstract][Full Text] [Related]
18. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.
Zhang Y; Lou Y; Wang J; Yu C; Shen W
Front Immunol; 2020; 11():609705. PubMed ID: 33552068
[TBL] [Abstract][Full Text] [Related]
19. Effect and Molecular Mechanisms of Traditional Chinese Medicine on Tumor Targeting Tumor-Associated Macrophages.
He J; Yin P; Xu K
Drug Des Devel Ther; 2020; 14():907-919. PubMed ID: 32184560
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
Fukushima M; Sakamoto K; Ohshimo H; Nakagawa F; Taguchi T
Oncol Rep; 2010 Oct; 24(4):835-42. PubMed ID: 20811661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
